Agustina A Pontecorvo, Jorge Cornejo, Steven Bowers, Enrique F Elli
{"title":"袖式胃切除术后复发性体重增加:十二指肠转换是否优于Roux-en-Y胃旁路术?","authors":"Agustina A Pontecorvo, Jorge Cornejo, Steven Bowers, Enrique F Elli","doi":"10.1007/s11695-025-08334-1","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Rates of conversion procedures after Sleeve Gastrectomy have been reported to reach up to 12.2% in 10 years of follow-up. The aim of this study was to compare perioperative outcomes and weight changes in patients who underwent either conversion from SG to Roux-en-Y Gastric Bypass (C-RYGB) or Duodenal Switch (C-DS).</p><p><strong>Methods: </strong>This study was a nonrandomized, controlled, retrospective review of 100 patients who underwent conversion of LSG due to recurrent weight gain at our institution from May 2015 to November 2024. Perioperative and postoperative variables were examined.</p><p><strong>Results: </strong>Of 481 SGs, 100 patients (90 C-RYGB; 10 C-DS) underwent conversion due to recurrent weight gain. The C-DS group had a higher preoperative BMI compared to C-RYGB (57.2 kg/m<sup>2</sup> vs 38.9 kg/m<sup>2</sup>, p < 0.001). Additionally, C-DS showed shorter operative time (142.5 min vs 193.8 min, p = 0.02) and similar length of hospitalization than C-RYGB. There was no significant difference in late reoperation rate between groups (13 [14.4%] C-RYGB vs 2 [20%] C-DS). The C-DS group had significant differences in %TWL at 6-,12- and 24-month follow-up with values of 21% vs 15.5%, 30% vs 18.2% and 33% vs 19% over C-RYGB, respectively. Excess preoperative BMI at the time of conversion was associated with a greater weight loss (each 1 kg/m<sup>2</sup> increase yielded 0.7% greater %TWL). However, no significant correlation was found between these two variables (p = 0.24, R<sup>2</sup> = 0.05).</p><p><strong>Conclusions: </strong>C-DS appears to be safe and feasible for the surgical management of recurrent weight gain after LSG. In addition, C-DS provides a significantly higher %TWL on 6, 12 and 24 months compared to C-RYGB.</p>","PeriodicalId":19460,"journal":{"name":"Obesity Surgery","volume":" ","pages":""},"PeriodicalIF":3.1000,"publicationDate":"2025-10-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Recurrent Weight Gain after Sleeve Gastrectomy: Is Conversion to Duodenal Switch Superior to Roux-en-Y Gastric Bypass?\",\"authors\":\"Agustina A Pontecorvo, Jorge Cornejo, Steven Bowers, Enrique F Elli\",\"doi\":\"10.1007/s11695-025-08334-1\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Rates of conversion procedures after Sleeve Gastrectomy have been reported to reach up to 12.2% in 10 years of follow-up. The aim of this study was to compare perioperative outcomes and weight changes in patients who underwent either conversion from SG to Roux-en-Y Gastric Bypass (C-RYGB) or Duodenal Switch (C-DS).</p><p><strong>Methods: </strong>This study was a nonrandomized, controlled, retrospective review of 100 patients who underwent conversion of LSG due to recurrent weight gain at our institution from May 2015 to November 2024. Perioperative and postoperative variables were examined.</p><p><strong>Results: </strong>Of 481 SGs, 100 patients (90 C-RYGB; 10 C-DS) underwent conversion due to recurrent weight gain. The C-DS group had a higher preoperative BMI compared to C-RYGB (57.2 kg/m<sup>2</sup> vs 38.9 kg/m<sup>2</sup>, p < 0.001). Additionally, C-DS showed shorter operative time (142.5 min vs 193.8 min, p = 0.02) and similar length of hospitalization than C-RYGB. There was no significant difference in late reoperation rate between groups (13 [14.4%] C-RYGB vs 2 [20%] C-DS). The C-DS group had significant differences in %TWL at 6-,12- and 24-month follow-up with values of 21% vs 15.5%, 30% vs 18.2% and 33% vs 19% over C-RYGB, respectively. Excess preoperative BMI at the time of conversion was associated with a greater weight loss (each 1 kg/m<sup>2</sup> increase yielded 0.7% greater %TWL). However, no significant correlation was found between these two variables (p = 0.24, R<sup>2</sup> = 0.05).</p><p><strong>Conclusions: </strong>C-DS appears to be safe and feasible for the surgical management of recurrent weight gain after LSG. In addition, C-DS provides a significantly higher %TWL on 6, 12 and 24 months compared to C-RYGB.</p>\",\"PeriodicalId\":19460,\"journal\":{\"name\":\"Obesity Surgery\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":3.1000,\"publicationDate\":\"2025-10-18\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Obesity Surgery\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1007/s11695-025-08334-1\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"SURGERY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Obesity Surgery","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s11695-025-08334-1","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"SURGERY","Score":null,"Total":0}
引用次数: 0
摘要
背景:据报道,在10年的随访中,袖胃切除术后的转换手术率高达12.2%。本研究的目的是比较SG转Roux-en-Y胃旁路术(C-RYGB)或十二指肠转换术(C-DS)患者的围手术期结局和体重变化。方法:本研究是一项非随机、对照、回顾性研究,纳入了2015年5月至2024年11月在我院因复发性体重增加而接受LSG转化的100例患者。检查围手术期和术后变量。结果:在481例SGs中,100例患者(90例C-RYGB; 10例C-DS)因复发性体重增加而发生转化。与C-RYGB组相比,C-DS组的术前BMI更高(57.2 kg/m2 vs 38.9 kg/m2, p 2增加导致%TWL增加0.7%)。但两变量间无显著相关(p = 0.24, R2 = 0.05)。结论:对于LSG术后复发性体重增加的手术治疗,C-DS似乎是安全可行的。此外,与C-RYGB相比,C-DS在6、12和24个月提供了显著更高的%TWL。
Recurrent Weight Gain after Sleeve Gastrectomy: Is Conversion to Duodenal Switch Superior to Roux-en-Y Gastric Bypass?
Background: Rates of conversion procedures after Sleeve Gastrectomy have been reported to reach up to 12.2% in 10 years of follow-up. The aim of this study was to compare perioperative outcomes and weight changes in patients who underwent either conversion from SG to Roux-en-Y Gastric Bypass (C-RYGB) or Duodenal Switch (C-DS).
Methods: This study was a nonrandomized, controlled, retrospective review of 100 patients who underwent conversion of LSG due to recurrent weight gain at our institution from May 2015 to November 2024. Perioperative and postoperative variables were examined.
Results: Of 481 SGs, 100 patients (90 C-RYGB; 10 C-DS) underwent conversion due to recurrent weight gain. The C-DS group had a higher preoperative BMI compared to C-RYGB (57.2 kg/m2 vs 38.9 kg/m2, p < 0.001). Additionally, C-DS showed shorter operative time (142.5 min vs 193.8 min, p = 0.02) and similar length of hospitalization than C-RYGB. There was no significant difference in late reoperation rate between groups (13 [14.4%] C-RYGB vs 2 [20%] C-DS). The C-DS group had significant differences in %TWL at 6-,12- and 24-month follow-up with values of 21% vs 15.5%, 30% vs 18.2% and 33% vs 19% over C-RYGB, respectively. Excess preoperative BMI at the time of conversion was associated with a greater weight loss (each 1 kg/m2 increase yielded 0.7% greater %TWL). However, no significant correlation was found between these two variables (p = 0.24, R2 = 0.05).
Conclusions: C-DS appears to be safe and feasible for the surgical management of recurrent weight gain after LSG. In addition, C-DS provides a significantly higher %TWL on 6, 12 and 24 months compared to C-RYGB.
期刊介绍:
Obesity Surgery is the official journal of the International Federation for the Surgery of Obesity and metabolic disorders (IFSO). A journal for bariatric/metabolic surgeons, Obesity Surgery provides an international, interdisciplinary forum for communicating the latest research, surgical and laparoscopic techniques, for treatment of massive obesity and metabolic disorders. Topics covered include original research, clinical reports, current status, guidelines, historical notes, invited commentaries, letters to the editor, medicolegal issues, meeting abstracts, modern surgery/technical innovations, new concepts, reviews, scholarly presentations and opinions.
Obesity Surgery benefits surgeons performing obesity/metabolic surgery, general surgeons and surgical residents, endoscopists, anesthetists, support staff, nurses, dietitians, psychiatrists, psychologists, plastic surgeons, internists including endocrinologists and diabetologists, nutritional scientists, and those dealing with eating disorders.